Works matching DE "GENETIC mutation"

Results: 5000
    1
    2
    3
    4
    5
    6
    7
    8

    In‐frame insertions of SOX10 are highly enriched and characterize a distinct transcriptomic profile in gastrointestinal schwannomas.

    Published in:
    Journal of Pathology, 2025, v. 266, n. 3, p. 268, doi. 10.1002/path.6426
    By:
    • Lee, Pei‐Hang;
    • Huang, Shih‐Chiang;
    • Lee, Jen‐Chieh;
    • Li, Sung‐Chou;
    • Tsai, Jen‐Wei;
    • Chang, Yi‐Ming;
    • Kao, Yu‐Chien;
    • Fan, Wen‐Lang;
    • Chang, Ching‐Di;
    • Chen, Hui‐Chun;
    • Li, Chih‐Hao;
    • Hu, Chia‐Fa;
    • Liu, Ting‐Ting;
    • Wu, Pao‐Shu;
    • Nam, Mann‐Hua;
    • Yu, Shih‐Chen;
    • Wang, Jui‐Chu;
    • Huang, Hsuan‐Ying
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Comprehensive analysis of molecular markers linked to antimalarial drug resistance in Plasmodium falciparum in Northern, Northeastern and Eastern Uganda.

    Published in:
    Malaria Journal, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12936-025-05439-x
    By:
    • Olupot-Olupot, Peter;
    • Paasi, George;
    • Katairo, Thomas;
    • Alunyo, Jimmy Patrick;
    • Nakiyemba, Alice;
    • Ocen, Gilbert Gilibrays;
    • Pande, Stephen;
    • Alaroker, Florance;
    • Okiror, William;
    • Ocen, Emmaluel;
    • Oula, Alex;
    • Okalebo, Charles Benard;
    • Paul, Ongodia;
    • Amorut, Denis;
    • Tukwasibwe, Stephen;
    • Ndidde, Susan Nabadda;
    • Sewanyana, Isaac;
    • Nsobya, Samuel L.
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    NF2 loss-of-function and hypoxia drive radiation resistance in grade 2 meningiomas Open Access.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 6, p. 1175, doi. 10.1093/jnci/djaf022
    By:
    • Patel, Bhuvic;
    • Pugazenthi, Sangami;
    • English, Collin W;
    • Nitturi, Vijay;
    • Pari, Shree S;
    • Mahlokozera, Tatenda;
    • Leidig, William A;
    • Lu, Hsiang-Chih;
    • Yang, Alicia;
    • Roberts, Kaleigh;
    • DeSouza, Patrick;
    • McGeehan, Kyle P;
    • Mao, Diane D;
    • Sinha, Namita;
    • Ippolito, Joseph E;
    • Dahiya, Sonika;
    • Petti, Allegra;
    • Yano, Hiroko;
    • Klisch, Tiemo J;
    • Harmanci, Akdes S
    Publication type:
    Article
    36
    37
    38
    39
    40
    41

    Clinical and Morphological Features of ER-Positive HER2-Negative Breast Tumors with PIK3CA Mutations in Russian Patients.

    Published in:
    Cancers, 2025, v. 17, n. 11, p. 1833, doi. 10.3390/cancers17111833
    By:
    • Sokolova, Tatyana N.;
    • Yanus, Grigory A.;
    • Aleksakhina, Svetlana N.;
    • Belysheva, Yana V.;
    • Chernyakova, Aleksandra P.;
    • Zharnakova, Yulia S.;
    • Nikitina, Alisa S.;
    • Stebneva, Tatyana M.;
    • Martianov, Aleksandr S.;
    • Goryainova, Alla Yu.;
    • Gluzman, Mark I.;
    • Orlova, Rashida V.;
    • Stukan', Anastasiya I.;
    • Zyuzyukina, Alena V.;
    • Zukov, Ruslan A.;
    • Korzun, Polina R.;
    • Binnatova, Jeyla O.;
    • Abuzova, Anastasia S.;
    • Murunova, Yulia N.;
    • Sultanbaev, Aleksandr V.
    Publication type:
    Article
    42
    43
    44

    Baseline Radiomics as a Prognostic Tool for Clinical Benefit from Immune Checkpoint Inhibition in Inoperable NSCLC Without Activating Mutations.

    Published in:
    Cancers, 2025, v. 17, n. 11, p. 1790, doi. 10.3390/cancers17111790
    By:
    • Moiseenko, Fedor;
    • Radulovic, Marko;
    • Tsvetkova, Nadezhda;
    • Chernobrivceva, Vera;
    • Gabina, Albina;
    • Oganesian, Any;
    • Makarkina, Maria;
    • Elsakova, Ekaterina;
    • Krasavina, Maria;
    • Barsova, Daria;
    • Artemeva, Elizaveta;
    • Khenshtein, Valeria;
    • Levchenko, Natalia;
    • Chubenko, Viacheslav;
    • Egorenkov, Vitaliy;
    • Volkov, Nikita;
    • Bogdanov, Alexei;
    • Moiseyenko, Vladimir
    Publication type:
    Article
    45
    46
    47
    48

    Niraparib Plus Aromatase Inhibitors for Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with a Germline BRCA Mutation.

    Published in:
    Cancers, 2025, v. 17, n. 11, p. 1744, doi. 10.3390/cancers17111744
    By:
    • Lema, Laura;
    • Pérez-García, José Manuel;
    • Blanch, Salvador;
    • Balmaña, Judith;
    • García-Sáenz, José Ángel;
    • Vegas, Elena Filipovich;
    • Jiménez, Begoña;
    • de la Haba, Juan;
    • Campolier, Marta;
    • Shimizu, Eileen;
    • Alcalá-López, Daniel;
    • Sampayo-Cordero, Miguel;
    • Cortés, Javier;
    • Llombart-Cussac, Antonio
    Publication type:
    Article
    49
    50